Yes, cannabis can trigger psychosis in some people. The risk depends heavily on how potent the product is, how often you use it, your age, and your genetic makeup. Most people who use cannabis will never experience a psychotic episode, but for a meaningful minority, the connection is real and well-documented.
What Cannabis-Related Psychosis Looks Like
Psychosis means losing touch with reality. In the context of cannabis, that can include hallucinations (seeing or hearing things that aren’t there), delusions (believing things that aren’t true, often paranoid in nature), or severely disorganized thinking. These symptoms can range from brief and mild to intense enough to require emergency care.
There’s an important distinction between two different experiences. The first is temporary psychotic symptoms during intoxication, which typically resolve within 24 hours as the high wears off. The second is a more sustained episode, formally called cannabis-induced psychotic disorder, where hallucinations or delusions persist for days or even weeks after the last use. If symptoms continue beyond a month, clinicians consider whether something longer-lasting, like a schizophrenia spectrum disorder, is developing.
THC Potency Is the Biggest Variable
THC is the compound in cannabis responsible for the high, and it’s also the one linked to psychosis. The more THC you consume, the higher the risk. A landmark study of 780 adults in the UK compared people experiencing their first psychotic episode with healthy controls. Those using high-potency cannabis (above 15% THC) had three times the risk of psychosis compared to non-users. Daily use of high-potency products pushed that to five times the risk. People who used low-potency hash (under 5% THC) showed no increased risk of psychotic symptoms at all.
This matters because cannabis has gotten dramatically stronger. Seized cannabis samples analyzed for the National Institute on Drug Abuse averaged 16.14% THC in 2022, and many dispensary products, especially concentrates and “wax dabs,” go far higher. That’s a very different substance than what was commonly available decades ago. Reports of psychosis following use of these ultra-high-potency products have been increasing.
CBD Doesn’t Appear to Offset the Risk
You may have heard that CBD, another compound in cannabis, protects against THC’s psychological effects. A randomized trial tested this directly, giving participants a fixed 10 mg dose of THC alongside varying amounts of CBD (none, 10 mg, 20 mg, or 30 mg). The THC-only condition reliably induced psychotic symptoms and impaired memory. Adding CBD at any dose made no significant difference. At the ratios found in most recreational and medicinal products, the researchers found no evidence that CBD reduces the acute adverse effects of THC on cognition or mental health.
This finding challenges a widely held assumption. Older observational data suggested that hash containing both THC and CBD carried less psychosis risk, but controlled experiments haven’t confirmed a protective effect from simply combining the two.
Synthetic Cannabinoids Are Far More Dangerous
Products sold as K2, Spice, or under other brand names contain synthetic cannabinoids that work on the same brain receptors as THC but hit much harder. THC is a partial activator of the brain’s cannabinoid receptors with relatively weak binding. Synthetic versions are full activators with stronger binding. The practical difference is enormous: a survey of 80,000 drug users found that those using synthetic cannabinoids were 30 times more likely to end up in an emergency room than natural cannabis users. Agitation, paranoia, and psychosis are commonly reported with these products.
Adolescents Face Higher Risk
The teenage brain is still developing, and cannabis use during this window carries outsized consequences. A large study published in JAMA Health Forum found that adolescents who used cannabis in the past year had roughly double the risk of developing a psychotic disorder compared to those who didn’t (an adjusted hazard ratio of 2.19). This held up even after excluding teens who already had a history of mental health conditions, where the hazard ratio was still 1.99. Cannabis use during adolescence was also linked to elevated rates of bipolar disorder, depression, and anxiety, but the psychosis connection was the strongest.
Genetics Play a Real Role
Not everyone’s brain responds to THC the same way, and part of that difference is genetic. A specific variant of the AKT1 gene (at a location called rs2494732) has been studied across multiple populations. People who carry two copies of the C version of this gene and use cannabis have more than double the risk of developing a psychotic disorder compared to carriers who don’t use. This finding was replicated in a separate study of 489 patients with first-episode psychosis. In controlled settings, the same genetic variant predicted how strongly someone’s psychotic-like symptoms flared after smoking cannabis.
An earlier theory pointed to a different gene involved in dopamine processing (COMT), but larger studies failed to confirm that connection. As of now, AKT1 is the most robust genetic marker identified. You can’t easily test for this at home, but if psychotic disorders run in your family, the overlap with cannabis vulnerability is worth taking seriously.
The Link to Long-Term Schizophrenia
One of the most sobering findings in this field involves what happens after a cannabis-induced psychotic episode. A study published in the American Journal of Psychiatry tracked over 3,000 patients diagnosed with substance-induced psychosis. Among those whose psychosis was triggered by cannabis, 36% were later diagnosed with a schizophrenia spectrum disorder within six years. That was the highest conversion rate of any substance studied and comparable to the rates seen in people already considered at ultra-high risk for schizophrenia through other screening methods.
This doesn’t mean cannabis “causes” schizophrenia in a simple, direct way. Many of these individuals likely had an underlying vulnerability that cannabis brought to the surface. But the practical takeaway is the same: a psychotic episode triggered by cannabis is not always a one-time event. For more than a third of people, it turns out to be the first sign of a chronic condition.
Who Should Be Most Concerned
The risk factors stack. If you use high-potency products daily, started as a teenager, and have a family history of psychotic disorders, you’re carrying several risk multipliers at once. Any single factor raises the probability modestly. Combined, they raise it substantially.
Lower-potency products used occasionally by adults with no family history of psychosis carry a much smaller risk, though not zero. The dose-response pattern is consistent across studies: more THC, more often, at younger ages, equals more risk. There is no identified “safe” threshold of THC that eliminates psychosis risk entirely, but the difference between occasional low-potency use and daily high-potency use is the difference between a small elevation and a fivefold increase.